Stępień-Wojno Małgorzata, Ponińska Joanna, Biernacka Elżbieta K, Foss-Nieradko Bogna, Chwyczko Tomasz, Syska Paweł, Płoski Rafał, Bilińska Zofia T
Unit for Screening Studies in Inherited Cardiovascular Diseases, National Institute of Cardiology, 04-628 Warsaw, Poland.
Department of Medical Biology, National Institute of Cardiology, 04-628 Warsaw, Poland.
Diagnostics (Basel). 2020 Jun 27;10(7):435. doi: 10.3390/diagnostics10070435.
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is one of causes of sudden cardiac death in the young, especially in athletes. Diagnosis of CPVT may be difficult since all cardiological examinations performed at rest are usually normal, and exercise stress test-induced ventricular tachycardia is not commonly present. The identification of a pathogenic mutation in or is diagnostic in CPVT. We report on a 20-year-old athlete who survived two sudden cardiac arrests during swimming. Moreover, he suffered repeated syncopal spells on exercise. The diagnosis was made only following genetic testing using a multi-gene panel, and the p.Arg420Gln variant was identified. We present diagnostic and therapeutic issues in this young athlete with CPVT.
儿茶酚胺能性多形性室性心动过速(CPVT)是年轻人心脏性猝死的原因之一,尤其是运动员。CPVT的诊断可能很困难,因为静息时进行的所有心脏检查通常都是正常的,而且运动应激试验诱发的室性心动过速并不常见。发现RYR2或CASQ2基因的致病突变对CPVT具有诊断意义。我们报告了一名20岁的运动员,他在游泳时经历了两次心脏骤停后幸存下来。此外,他在运动时反复出现晕厥发作。仅在使用多基因检测板进行基因检测后才做出诊断,并鉴定出p.Arg420Gln变异。我们介绍了这位患有CPVT的年轻运动员的诊断和治疗问题。